A股異動 | 京東方A(000725.SZ)漲約4% 已向iPhone13供屏出貨
格隆匯11月3日丨京東方A(000725.SZ)漲約4%,報5.04元,總市值1938億元。據瞭解,京東方在位於綿陽的B11工廠內設立了專供蘋果的柔性OLED面板產線,近期綿陽B11工廠出貨量明顯增加。京東方官方雖未對此迴應,但據知情人士透露,新款iPhone13屏幕已在京東方綿陽產線順利量產出貨。目前京東方已通過蘋果公司的資格審查,正式進入iPhone 13顯示屏量產階段,成為參與iPhone新品供應的唯一國產面板廠商。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.